These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 20307649)
1. Testis dysfunction by isoproterenol is mediated by upregulating endothelin receptor A, leptin and protein kinase Cvarepsilon and is attenuated by an endothelin receptor antagonist CPU0213. Cheng YS; Dai DZ; Dai Y Reprod Toxicol; 2010 Jul; 29(4):421-6. PubMed ID: 20307649 [TBL] [Abstract][Full Text] [Related]
2. Stress-induced cardiac insufficiency relating to abnormal leptin and FKBP12.6 is ameliorated by CPU0213, an endothelin receptor antagonist, which is not affected by the CYP3A suppressing effect of erythromycin. Cheng YS; Dai DZ; Dai Y J Pharm Pharmacol; 2009 May; 61(5):569-76. PubMed ID: 19405994 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of the endothelin antagonist CPU0213 against isoprenaline-induced heart failure by suppressing abnormal expression of leptin, calcineurin and SERCA2a in rats. Xu M; Ji H; Dai DZ; Tang XY; Dai Y J Pharm Pharmacol; 2008 Jun; 60(6):739-45. PubMed ID: 18498710 [TBL] [Abstract][Full Text] [Related]
4. The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature. Xu J; Li N; Dai DZ; Yu F; Dai Y J Cardiovasc Pharmacol; 2008 Jul; 52(1):42-8. PubMed ID: 18594475 [TBL] [Abstract][Full Text] [Related]
5. Reversal of isoproterenol-induced downregulation of phospholamban and FKBP12.6 by CPU0213-mediated antagonism of endothelin receptors. Feng Y; Tang XY; Dai DZ; Dai Y Acta Pharmacol Sin; 2007 Nov; 28(11):1746-54. PubMed ID: 17959025 [TBL] [Abstract][Full Text] [Related]
6. Endothelin receptor antagonist CPU0213 and vitamin E reverse downregulation of FKBP12.6 and SERCA2a: a role of hyperphosphorylation of PKCepsilon. Li N; Jia N; Dai DZ; Dai Y Eur J Pharmacol; 2008 Sep; 591(1-3):211-8. PubMed ID: 18611397 [TBL] [Abstract][Full Text] [Related]
7. Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin. Luo L; Zheng YF; Dai Y; Dai DZ J Pharm Pharmacol; 2009 Jun; 61(6):775-80. PubMed ID: 19505368 [TBL] [Abstract][Full Text] [Related]
8. Effect of the endothelin receptor antagonist CPU0213, and its modulation by rifampin, on cardiac and vascular tissue following chronic isoproterenol treatment. Luo L; Dai DZ; Dai Y Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):757-65. PubMed ID: 18215179 [TBL] [Abstract][Full Text] [Related]
9. Role of endothelin in the effects of isoprenaline on potassium currents and calsequestrin 2 expression in the heart. Li N; Jia N; Dai DZ; Hu C; Dai Y Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):557-63. PubMed ID: 20529095 [TBL] [Abstract][Full Text] [Related]
10. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Xu FP; Chen MS; Wang YZ; Yi Q; Lin SB; Chen AF; Luo JD Circulation; 2004 Sep; 110(10):1269-75. PubMed ID: 15313952 [TBL] [Abstract][Full Text] [Related]
11. Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni. Su W; Dai DZ; Liu HR; Na T; Dai Y Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1228-33. PubMed ID: 17973859 [TBL] [Abstract][Full Text] [Related]
12. Chronic exposure to perfluorododecanoic acid disrupts testicular steroidogenesis and the expression of related genes in male rats. Shi Z; Ding L; Zhang H; Feng Y; Xu M; Dai J Toxicol Lett; 2009 Aug; 188(3):192-200. PubMed ID: 19397962 [TBL] [Abstract][Full Text] [Related]
13. Leptin increases endothelin type A receptor levels in vascular smooth muscle cells. Juan CC; Chuang TY; Lien CC; Lin YJ; Huang SW; Kwok CF; Ho LT Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E481-7. PubMed ID: 18056787 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; RosanĂ² L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
15. Interaction between endothelin and angiotensin II in the up-regulation of vasopressin messenger RNA in the inner medullary collecting duct of the rat. Wang MH; Fok A; Huang MH; Wong NL Metabolism; 2007 Oct; 56(10):1372-6. PubMed ID: 17884447 [TBL] [Abstract][Full Text] [Related]
16. Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCepsilon in the heart, which are mitigated by endothelin receptor antagonist CPU0213. Cheng YS; Dai DZ; Dai Y Acta Pharmacol Sin; 2009 Aug; 30(8):1099-106. PubMed ID: 19597524 [TBL] [Abstract][Full Text] [Related]
17. Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats. Xu M; Dai DZ; Dai Y Am J Nephrol; 2009; 29(3):252-6. PubMed ID: 18802327 [TBL] [Abstract][Full Text] [Related]
18. Di (n-butyl) phthalate inhibits testosterone synthesis through a glucocorticoid-mediated pathway in rats. Xiao-feng Z; Nai-qiang Q; Jing Z; Zi L; Yang Z Int J Toxicol; 2009; 28(5):448-56. PubMed ID: 19815848 [TBL] [Abstract][Full Text] [Related]
19. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats. Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320 [TBL] [Abstract][Full Text] [Related]
20. Endothelin-2 induces oviductal contraction via endothelin receptor subtype A in rats. Al-Alem L; Bridges PJ; Su W; Gong MC; Iglarz M; Ko C J Endocrinol; 2007 Jun; 193(3):383-91. PubMed ID: 17535876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]